top of page
< Back

Metabolic Dysregulation and Pancreatic Adenocarcinoma: Sex-specific Expression of MOGAT3

Authors

Juliana Ponomarenko-Jakunin, Center of Internal Medicine/ Sex and Gender Specific Medicine and Prevention, University Hospital Magdeburg, Germany
James Koch, Department of Molecular and Experimental Surgery, University Clinic for General, Visceral, Vascular and Transplant Surgery, Magdeburg, Germany
Thomas Wartmann, Department of Molecular and Experimental Surgery, University Clinic for General, Visceral, Vascular and Transplant Surgery, Magdeburg, Germany
Ahmed Sanin, Department of Molecular and Experimental Surgery, University Clinic for General, Visceral, Vascular and Transplant Surgery, Magdeburg, Germany
Arslan Ghazanfar, Department of Molecular and Experimental Surgery, University Clinic for General, Visceral, Vascular and Transplant Surgery, Magdeburg, Germany
Dhanush Damodaran, Department of Molecular and Experimental Surgery, University Clinic for General, Visceral, Vascular and Transplant Surgery, Magdeburg, Germany
Ulf Kahlert, Department of Molecular and Experimental Surgery, University Clinic for General, Visceral, Vascular and Transplant Surgery, Magdeburg ,Germany
Ute Seeland, Center of Internal Medicine/ Sex and Gender Specific Medicine and Prevention, University Hospital Magdeburg, Magdeburg, Germany

Metabolic Dysregulation and Pancreatic Adenocarcinoma: Sex-specific Expression of MOGAT3
Previous
Next
Logo of the Swiss Gender Medicine Symposium including male and female gender symbol

Contact information:

PHONE:

E-MAIL:

CONTACT:

University of Zurich

Universitäre Medizin Zürich UMZH

Direktion UMZH

Künstlergasse 15  

CH - 8001 Zürich

  • LinkedIn
  • Instagram
  • Facebook

SOCIAL MEDIA:

Would you like to find out more about the Swiss Gender Medicine Symposium?

Subscribe to our newsletter!

Language
German
English
French

Copyright © 2024 by Swiss Gender Medicine Symposium. All Rights Reserved | PRIVACY POLICY | IMPRINT

bottom of page